Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 36,766 | 25,245 | 34,696 | 33,946 | 105,412 |
| Gross Profit | 36,766 | 25,245 | 34,696 | 33,946 | 105,412 |
| Operating Expenses | 203,896 | 124,658 | 80,094 | 60,754 | 74,830 |
| Operating Income | -167,130 | -99,413 | -45,398 | -26,808 | 30,582 |
| Interest Expense | 2,367 | 0 | 6,084 | 1,210 | 2,444 |
| Other Income | -465 | 967 | -92 | 1,783 | 461 |
| Pre-tax Income | -169,962 | -98,446 | -51,574 | -26,235 | 28,599 |
| Income Tax | 485 | -4,693 | N/A | N/A | -2,306 |
| Net Income Continuous | -170,447 | -93,753 | -51,574 | -26,235 | 30,905 |
| Net Income | $-170,447 | $-93,753 | $-51,574 | $-26,235 | $30,905 |
| EPS Basic Total Ops | -5.07 | -2.97 | -5.18 | 219.76 | N/A |
| EPS Basic Continuous Ops | -5.07 | -2.97 | -4.02 | -7,883.11 | N/A |
| EPS Diluted Total Ops | -5.07 | -2.97 | -5.18 | 42.50 | N/A |
| EPS Diluted Continuous Ops | -5.07 | -2.97 | -4.02 | -1,524.85 | N/A |
| EBITDA(a) | $-161,667 | $-95,571 | $-43,002 | $-24,104 | $33,453 |